One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration is a research paper published in Translational Vision Science & Technology (2021). On theSindex it has a DataRank of 0. It has been cited 88 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
MeSH Terms
Additional file 1 of Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
Additional file 1 of Changes in best-corrected visual acuity in patients with dry age-related macular degeneration after stem cell transplantation: systematic review and meta-analysis
Additional file 1 of Determining the optimal stage for cryopreservation of human embryonic stem cell-derived retinal pigment epithelial cells
Additional file 1 of Determining the optimal stage for cryopreservation of human embryonic stem cell-derived retinal pigment epithelial cells
Additional file 1 of Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis
Additional file 1 of Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis
Additional file 2 of Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis
Additional file 2 of Cell therapy for retinal degenerative disorders: a systematic review and three-level meta-analysis